The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy

The promising treatment combination of ionizing radiation (IR) with a hypoxia-activated prodrug (HAP) is based on biological cooperation. Here we investigated the hypoxia-activated prodrug evofosfamide in combination with different treatment regimens of IR against lung A549- and head&neck UT-SCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Nytko, Katarzyna J., Grgic, Ivo, Bender, Sabine, Ott, Janosch, Guckenberger, Matthias, Riesterer, Oliver, Pruschy, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410338/
https://www.ncbi.nlm.nih.gov/pubmed/28423594
http://dx.doi.org/10.18632/oncotarget.15784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410338/
https://www.ncbi.nlm.nih.gov/pubmed/28423594
http://dx.doi.org/10.18632/oncotarget.15784

Ejemplares similares